For two decades, PAREXEL International has played a key role in the pharmaceutical, biotechnology and medical device industries by partnering with clients to accelerate time-to-market, control development costs, reduce risk, and maximize return on investment. As one of the largest pharmaceutical services companies in the world, PAREXEL delivers a full range of services and solutions through its offices in 36 countries.
We have helped over 800 clients develop and launch some of the most important drugs and devices of our time. In fact, a recent study showed that we have played a role in the development of 19 of the top 20 drugs introduced in 1999 and 23 out of the top 25 drugs introduced in 2000. Our services are unmatched in the industry and include strategy development, clinical trials management, data management, biostatistical analysis, regulatory affairs, medical marketing, training, publishing and advanced technology.
Our more than 5,100 employees worldwide represent the widest possible range of therapeutic experience and knowledge. We provide centralized management and consistency for even the largest global trials and multi-site research.
Our strategic business units are:
· Clinical Research Services — clinical development services
· PAREXEL Consulting Group — consulting services and products
· Medical Marketing Services (MMS) — product launch and post-launch services
· Perceptive Informatics, Inc. — advanced technology
Poitiers, France : PAREXEL Bioanalytical Laboratories
This Laboratory was established in Poitiers, France, in 1977.
The modern, GLP-certified Bioanalytical Laboratory supports both internal and external preclinical and clinical trials and full development programs. An experienced staff, many of which have been with the Laboratory since it was founded, specialize in developing highly sensitive assays that combine mass spectrometry with chromatography. More than 300 assay methods have been developed in-house.
As a certified training center in France, unique training seminars on applied GC-MS and LC-MS/MS are offered. These capabilities and facilities, combined with the expertise and flexibility in terms of materials and personnel, allows the Unit to participate in the analysis of large numbers of samples in a short period of time using:
· 6 LC-MS/MS (API 3000: ESP, TIS, APCI)
· 6 GC-MS (HP 5988, HP 5989: EI, PICI, NICI)
· 14 HPLC systems (UV, Fluorimetry, ECD) including
· 4HPLC-MS (Particle beam interfaces)
